Prognostic Value of Biomarkers in Polyneuropathy.

Status Recruiting

Clinical Trial Summary

Biomarkers for prognosis of patients with polyneuropathy.

Clinical Trial Description

AIM: To investigate biomarkers' use as a prognostic tool in polyneuropathy patients. STUDY DESIGN: Prospective cohort study of patients with polyneuropathy. METHODS: 200 patients with polyneuropathy will be examined with physical tests, medical examination, questionnaires, and blood biomarkers at baseline and at 1-year follow-up, and 2-year follow-up. ANALYSIS: The investigators will calculate the odds of disease progression after 2 years depending on biomarkers levels at baseline using multiple logistic regression with sex and age adjustment. Diagnostic performance of the physical tests and biomarkers for prediction of disease progression will be assessed by Receiver Operating Characteristic Curve analysis with the area under the curve. ;

Study Design

Related Conditions & MeSH terms

Polyneuropathies

Clinical Trial Details

NCT number	NCT06044662
Study type	Observational
Source	Rigshospitalet, Denmark
Contact	Tina Dysgaard, Dr.med.
Phone	±45 35458077
Email	Tina.dysgaard@regionh.dk
Status	Recruiting
Phase
Start date	October 27, 2023
Completion date	October 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06040567` - Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
Enrolling by invitation	`NCT04461613` - Physical Activity in Persons With Charcot-Marie-Tooth: Developing a Measurement Instrument	N/A
Enrolling by invitation	`NCT06359561` - Assessment of Effectiveness and Stimulation Coverage of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Patients With Cervical Lead Placement
Completed	`NCT00050245` - Rituximab to Treat Neuropathy With Anti-MAG Antibodies	Phase 2
Not yet recruiting	`NCT01718015` - Neurotrophic Factors in Cerebrospinal Fluid in Diabetic Patients With Polyneuropathy	N/A
Completed	`NCT03765489` - Electrical Muscle Stimulation in the Development of Acquired Weakness in Patients With Severe Sepsis and Septic Shock	N/A
Completed	`NCT01370837` - Neurogenic Inflammation in Diabetes	N/A
Not yet recruiting	`NCT02061059` - Cost-effectiveness of In-shoe Pressure Measurement for Therapeutic Shoes	N/A
Recruiting	`NCT06377033` - Using the EHR to Advance Genomic Medicine Across a Diverse Health System	N/A
Not yet recruiting	`NCT06390527` - Ultrasonography in Diagnosis of Polyneuropathy
Recruiting	`NCT05188690` - Polyneuropathy and COVID-19
Completed	`NCT00231673` - A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy	Phase 2
Recruiting	`NCT03237494` - TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects
Active, not recruiting	`NCT03617185` - Effect of Exercise and Surgical Weight Loss on Polyneuropathy	N/A
Active, not recruiting	`NCT02753036` - Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer
Completed	`NCT01263132` - Neuropathic Pain Management	Phase 3
Terminated	`NCT01867645` - The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis	Phase 1
Completed	`NCT00162968` - Escitalopram as a Treatment for Pain in Polyneuropathy	Phase 4
Completed	`NCT04664426` - Sensory Neuropathy Scores Validated by Quantitative Sensory Testing and Nerve Conduction Studies for Kidney Transplant Recipients
Recruiting	`NCT05023889` - Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy	Early Phase 1